0ET.MU

Esperion Therapeutics Inc
MunichEUREQUITY DELAYED
Last price
2.76
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
2.76
Day high
Day low
Volume
Market cap
P/E (TTM)
52W range
— – 3.42

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+0.47% +1.7%
1M
+3.41% +0.1%
3M
+45.38% +43.0%
6M
-11.50% -23.4%
YTD
-18.08% -30.0%
1Y
+168.91% +148.8%
3Y
+101.97% +27.0%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on 0ET.MU open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 6 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $403.13M$332.31M$116.33M$75.47M +21.3%
Operating revenue $403.13M$332.31M$116.33M$75.47M +21.3%
Cost of revenue $129.22M$68.60M$43.27M$26.97M +88.4%
Gross profit $273.91M$263.71M$73.07M$48.51M +3.9%
Research & development $47.85M$46.24M$86.11M$118.93M +3.5%
Selling, general & admin $165.79M$163.07M$142.52M$109.08M +1.7%
Total operating expense $213.64M$209.31M$228.63M$228.01M +2.1%
Operating income $60.27M$54.40M-$155.56M-$179.50M +10.8%
Net interest income -$84.60M-$59.25M-$58.98M-$56.81M -42.8%
Pre-tax income -$20.84M-$51.74M-$209.25M-$233.66M +59.7%
Tax provision $1.84M$0$0
Net income -$22.68M-$51.74M-$209.25M-$233.66M +56.2%
Net income to common -$22.68M-$51.74M-$209.25M-$233.66M +56.2%
Basic EPS -0.11-0.28-2.03-3.52 +60.7%
Diluted EPS -0.11-0.28-2.03-3.52 +60.7%
EBIT $63.76M$7.51M-$150.27M-$176.85M +749.5%
EBITDA $63.87M$7.57M-$150.11M-$176.35M +743.8%
Basic shares 207.87M187.18M103.11M66.41M +11.0%
Diluted shares 207.87M187.18M103.11M66.41M +11.0%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
2.75
+0.48% from price
SMA 20
2.74
+0.96% from price
SMA 50
2.69
+2.84% from price
SMA 100
2.48
+11.62% from price
SMA 200
2.62
+5.28% from price
EMA 12
2.75
+0.63% from price
EMA 26
2.71
+1.88% from price
EMA 50
2.64
+4.66% from price
RSI (14)
79.2
Overbought
MACD (12,26,9)
0.03
Hist -0.01
ATR (14)
0.00
0.11% of price
Realised vol 30D
7.0%
Annualised
Bollinger upper
2.79
20, 2σ
Bollinger lower
2.68
20, 2σ
50 / 200 cross
Golden
2.69 vs 2.62
Trend bias
Above 200
+5.28%

Options chain

Account required
Expiry
Spot 2.76
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.47
Less volatile than market
Correlation to SPY
0.07
Largely independent
Realised vol 30D
7.0%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-51.0%
Peak to trough
Max drawdown 5Y
-94.2%
Peak to trough
ATR 14
0.00
0.11% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.